Konstantina Katcheves

Konstantina Katcheves is a prominent professional in the pharmaceutical and biotechnology sectors, currently serving as the Chief Business and Strategy Officer at Acadia Pharmaceuticals Inc. since August 2025. With over 20 years of experience in business development and corporate leadership, Konstantina has held significant roles, including Senior Vice President at Teva Pharmaceuticals and Interim Head of Enterprise Strategy and Business Development at Bristol Myers Squibb. Notable contributions include advising as a board member at Codex Labs and Sekhmet Ventures, leading global intellectual property teams at Agilent Technologies and Lonza, and founding a law firm dedicated to intellectual property in life sciences. Educational credentials include a Master's in Biotechnology from The Johns Hopkins University, a JD from the University of Oklahoma, and a BS in Biochemistry and Cell Biology from UC San Diego.